Uremic toxin development in living kidney donors: a longitudinal study

Area of Science:

• Nephrology
• Cardiovascular Medicine
• Toxicology

Background:

• Uremic toxins, indoxyl sulfate (IS) and p-cresyl sulfate (PCS), are implicated in cardiovascular disease pathogenesis.
• IS and PCS levels rise in chronic kidney disease, but their post-nephrectomy effects in non-CKD patients are unknown.

Purpose of the Study:

• To investigate the impact of nephrectomy on IS and PCS levels in living kidney donors.
• To assess the association of these toxins with cardiovascular and renal risk markers post-nephrectomy.

Main Methods:

• Observational cohort study of 42 living kidney donors followed for 2 years post-nephrectomy.
• Measured serum IS/PCS, carotid intima-media thickness, brachial artery reactivity, kidney function (eGFR), urate, and hs-CRP.
• Utilized ultra-high-performance liquid chromatography for toxin quantification.

Main Results:

• Nephrectomy led to a 30% decrease in kidney function and a 44-100% increase in IS/PCS levels, sustained for 2 years.
• Elevated IS/PCS correlated with increased carotid intima-media thickness, endothelial dysfunction markers, urate, and hs-CRP.
• IS and urate independently predicted kidney function decline post-nephrectomy.

Conclusions:

• Nephrectomy causes significant, sustained increases in nephrovascular toxins IS and PCS.
• These toxin elevations are associated with key cardiovascular and renal risk factors, suggesting potential long-term health implications.